Trium Capital LLP
- SEC CIK
- 0001963860
- Latest filing
- Jul 16, 2026
ESPR holding history
Esperion Therapeutics, Inc. in every 13F filed by Trium Capital LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ESPR overviewAll 13F holders of ESPRFull Q2 2026 holdings
- Shares (Q2 2026)
- 11,158,150
- Value
- $35.3M
- % of portfolio
- 22.2%
- Quarters held
- 1
- Since Q2 2026